BIOMAT Database Logo BIOMAT Database Logo

[Viral hepatitis A: specific immunologic aspects before and after exposure to risk]. 1983

C Laverdant, and J Hainaut, and J Dutertre

UI MeSH Term Description Entries
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006507 Hepatovirus A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species. Hepatitis Virus, Infectious,Infectious Hepatitis Virus,Hepatitis Viruses, Infectious,Hepatoviruses,Infectious Hepatitis Viruses
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

C Laverdant, and J Hainaut, and J Dutertre
[Immunologic aspects of viral hepatitis].
April 1977, Der Internist,
C Laverdant, and J Hainaut, and J Dutertre
[Viral hepatitis: clinical aspects, immunologic markers and vaccination].
September 1982, Therapeutische Umschau. Revue therapeutique,
C Laverdant, and J Hainaut, and J Dutertre
[Immunologic aspects of acute viral hepatitis at different ages].
January 1986, Terapevticheskii arkhiv,
C Laverdant, and J Hainaut, and J Dutertre
[Viral hepatitis A and exposure to sewage: a confirmed occupational risk].
October 1995, Gastroenterologie clinique et biologique,
C Laverdant, and J Hainaut, and J Dutertre
[Immunologic aspects of the physiopathology of viral hepatitis B. 2. Chronic hepatitis].
November 1989, Gastroenterologie clinique et biologique,
C Laverdant, and J Hainaut, and J Dutertre
[Immunologic aspects of the physiopathology of viral hepatitis B. 1. Acute hepatitis].
November 1989, Gastroenterologie clinique et biologique,
C Laverdant, and J Hainaut, and J Dutertre
[Genetic and immunologic aspects of synovitis after viral infection].
September 1985, Vnitrni lekarstvi,
C Laverdant, and J Hainaut, and J Dutertre
[Hepatitis B virus, extrahepatic immunologic manifestations and risk of viral reactivation].
October 2011, La Revue de medecine interne,
C Laverdant, and J Hainaut, and J Dutertre
[Immunologic study of viral hepatitis].
January 1976, Annales de l'anesthesiologie francaise,
C Laverdant, and J Hainaut, and J Dutertre
Viral hepatitis--a risk to nurses.
July 1973, The Canadian nurse,
Copied contents to your clipboard!